STK16-IN-1 is an inhibitor of the serine/threonine kinase STK16 (IC50 = 295 nM).1 It is selective for STK16 over mTOR, PI3Kδ, and PI3Kγ in an enzyme assay (IC50s = 5,560, 856, and 867 nM, respectively) and over 440 additional kinases in a KinomeScan profiling assay. It decreases the growth of MCF-7 cells (GI50 = ~10 ?M) and increases the number of binucleated cells. STK16-IN-1 (2.5-5 ?M) potentiates the antiproliferative effects of colchicine , paclitaxel , doxorubicin , and cisplatin in MCF-7 cells.
1.Liu, F., Wang, J., Yang, X., et al.Discovery of a highly selective STK16 kinase inhibitorACS Chem. Biol.11(6)1537-1543(2016)
















